Business
Press Release Jul 14 2023
Lupin Limited has informed the Exchange regarding a press release dated July 14, 2023, titled "Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets. USP ".
About this update from Lupin Limited
[{"type":"text","content":" Lupin Limited has informed the Exchange regarding a press release dated July 14, 2023, titled \"Lupin Receives Approval from U.S. FDA for Chlorpromazine Hydrochloride Tablets. USP \". View Attachment","length":344,"tagName":"div"}]